SEARCH

SEARCH BY CITATION

References

  • [1]
    Talley, N.J. (1999) Irritable bowel syndrome: definition, diagnosis and epidemiology. Bailieres's Clin. Gastroenterol. 13, 371384.
  • [2]
    Thompson, W.G., Longstreth, G.F., Drossman, D.A., Heaton, K.W., Irvine, E.J., Müller-Lissner, S.A. (1999) Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl 2), II43II47.
  • [3]
    Camilleri, M. (2001) Management of the irritable bowel syndrome. Gastroenterology 120, 652668.
  • [4]
    Sach, J.A., Chang, L. (2002) Irritable bowel syndrome. Curr. Treat. Opt. Gastroenterol. 5, 267278.
  • [5]
    Longstreth, G.F., Wilson, A., Knight, K., Wong, J., Chiou, C.-F., Barghout, V., Frech, F., Ofman, J.J. (2003) Irritable bowel syndrome, health care use, and costs: A US managed care perspective. Am. J. Gastroenterol. 98, 600607.
    Direct Link:
  • [6]
    Horwitz, B.J., Fisher, R.S. (2001) Current concepts: The irritable bowel syndrome. New Engl. J. Med. 344, 18461850.
  • [7]
    Gwee, K.A. (2001) Postinfectious irritable bowel syndrome. Curr. Treatm. Opt. Gastroenterol. 4, 287291.
  • [8]
    Collins, S.M., Piche, T., Rampal, P. (2001) The putative role of imflammation in the irritable bowel syndrome. Gut 49, 743745.
  • [9]
    King, T.S., Elia, M., Hunter, J.O. (1998) Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352, 11871189.
  • [10]
    Attar, A., Flourié, B., Rambaud, J.-C., Franchisseur, C., Ruszniiewski, P., Bouhnik, Y. (1999) Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 117, 794797.
  • [11]
    Pimentel, M., Chow, E.J., Lin, H.C. (2000) Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am. J. Gastroenterol. 95, 35033506.
    Direct Link:
  • [12]
    Balsari, A., Ceccarelli, A., Dubini, F., Fesce, E., Poli, G. (1982) The fecal microbial population in the irritable bowel syndrome. Microbiologica 5, 185194.
  • [13]
    Bradley, H.K., Wyatt, G.M., Bayliss, C.E., Hunter, J.O. (1987) Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. J. Med. Microbiol. 23, 2932.
  • [14]
    Madden, J.A.J., Hunter, J.O. (2002) A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br. J. Nutr. 88, S67S72.
  • [15]
    Talley, N.J. (2003) Pharmacologic therapy for the irritable bowel syndrome. Am. J. Gastroenterol. 98, 750758.
    Direct Link:
  • [16]
    Petitpierre, M., Gumowski, P., Girard, J.-P. (1985) Irritable bowel syndrome and hypersensitivity to food. Ann. Allergy 54, 538540.
  • [17]
    Nobaek, S., Johansson, M.-L., Molin, G., Ahrné, S., Jeppson, B. (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 95, 12311238.
    Direct Link:
  • [18]
    Niedzielin, K., Kordecki, H., Birkenfeld, B. (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 13, 11431147.
  • [19]
    Kim, H.J., Camilleri, M., McKinzie, S., Lempke, M.B., Burton, B.B., Thomforde, G.M., Zinsmeister, A.R. (2003) A randomised controlled trial of a probiotic, VSL#3,on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 1, 895904.
  • [20]
    Alvarez-Olmos, M.I., Oberhelman, R.A. (2001) Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clin. Infect. Dis. 32, 15671576.
  • [21]
    Beerens, H. (1991) Detection of bifidobacteria by using propionic acid as a selective agent. Appl. Environ. Microbiol. 57, 24182419.
  • [22]
    Atlas, R.M. (1993) Handbook of Microbiological Media. CRC Press Inc., Boca Raton, FL, USA.
  • [23]
    Zoetendal, E.G., Akkermans, A.D.L., Akkermans-van Vliet, W.M., De Visser, J.A.G.M., De Vos, W.M. (2001) The host genotype affects the bacterial community in the human gastrointestinal tract. Microbiol. Ecol. Health Dis. 13, 129134.
  • [24]
    Nübel, U., Engelen, B., Felske, A., Snaidr, J., Wieshuber, A., Amann, R.I., Ludwig, W., Backhaus, H. (1996) Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J. Bacteriol. 178, 56365643.
  • [25]
    Bayliss, C.E., Bradley, H.K., Alun Jones, V., Hunter, J.O. (1986) Some aspects of colonic microbial activity in irritable bowel syndrome associated with food intolerance. Ann. Ist. Super. Sanita 22, 959964.
  • [26]
    Madden, J.A.J., Plummer, S., Sen, S., Dear, K., Tarry, S., Hunter, J.O. Comparison of the caecal and faecal microflora of healthy subjects and patients with irritable bowel syndrome (IBS) Gut 48 Suppl1 2001 A58
  • [27]
    Finegold, S.M., Sutter, V.L., Boyle, J.D., Shimada, K. (1970) The normal flora of ileostomy and transverse colostomy effluents. J. Infect. Dis. 122, 376381.
  • [28]
    Hopkins, M.J., Sharp, R., Macfarlane, G.T. (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198205.
  • [29]
    Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A., Corthier, G. (2001) Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl. Environ. Microbiol. 67, 49394942.
  • [30]
    Collins, M.D., Lawson, P.A., Willems, A., Cordoba, J.J., Fernandez-Garayzabal, J., Gaecia, P., Cai, J., Hippe, H., Farrow, J.A.E. (1994) The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 144, 812826.
  • [31]
    Tvede, M., Willumsen, L. Clostridium difficile in patients with irritable bowel syndrome and ulcerative colitis Lancet 15 1982 1124
  • [32]
    Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G., Collins, M.D., Doré, J. (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65, 47994807.
  • [33]
    Sghir, A., Gramet, G., Suau, A., Rochet, V., Pochart, P., Doré, J. (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66, 11662263.
  • [34]
    Rigottier-Gois, L., Le Bourhis, A.-G., Gramet, G., Rochet, V., Doré, J. (2003) Fluorescent in situ hybridizateion combined with flow cytometry and hybridization of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol. Ecol. 43, 237245.
  • [35]
    Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Marteau, P., Jian, R., Doré, J. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237242.
  • [36]
    Zoetendal, E.G., Akkermans, A.D.L., De Vos, W.M. (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64, 38543859.
  • [37]
    Vanhoutte, T., Huys, G., De Brandt, E., Swings, J. (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol. Ecol. 48, 437446.
  • [38]
    Edlund, C., Nord, C.E. (2000) Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J. Antimicrob. Chemother. 46, S41S48.
  • [39]
    Donskey, C.J., Hujer, A.M., Das, S.M., Pultz, N.J., Bonomo, R.A., Rice, L.B. (2003) Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Meth. 54, 249256.
  • [40]
    Bartosch, S., Fite, A., Macfarlane, G.T., McMurdo, M.E.T. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70, 35753581.
  • [41]
    Nord, C.E., Gajjar, D.A., Grasela, D.M. (2002) Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora. Clin. Microbiol. Infect. 8, 229239.